Promethera Biosciences to Attend Upcoming Scientific and Partnering Conferences

Mont-Saint-Guibert, Belgium, and Tokyo, Japan, September 12th, 2019 – Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced that the Company will give presentations and attend the following scientific and partnering conferences in Japan, Europe, and the US.


International Society of Cell Therapy Meeting

Date: September 13-15, 2019

Venue: Monona Terrace Community & Convention Center, Madison, WI, USA

  • Presentation:
    • Title: Plenary Session 1 - Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs
    • Date: September 13, 2019
    • Presenter: Etienne Sokal, M.D., Ph.D., Group CMO, acting CSO


2019 ISPE Europe Biotechnology Conference

Date: September 25-26, 2019

Venue: Crowne Plaza Brussels Airport Hotel, Brussels, Belgium

  • Presentation:
    • Title: Planning for Late Phase/Commercial Launch of Cell Therapy
    • Date: September 25, 2019
    • Presenter: Thierry Bovy, Director of Manufacturing


The Liver Meeting 2019 (AASLD)

Date: November 8-12, 2019

Venue: Hynes Convention Center, Boston, MA, USA

Booth: No. 628

  • Presentation:
    • Title: Safety and tolerability of liver-derived stem cells (HepaStem™) infused in patients with Acute-on-Chronic Liver Failure (ACLF or Acute Decompensation (AD) at risk of developing ACLF): a European phase I/II open-labelled study
    • Date: November 10th, 2019
    • Presenter: Etienne Sokal, M.D., Ph.D., Group CMO, acting CSO


BIO Europe  

Date: November 11-13, 2019

Venue: Hamburg Messe, Hamburg, Germany

Attendance: Henrik Luessen, PhD, CBO and Pascale Jordan, PhD, Director Business Development, External Evaluation


43rd Meeting of Western Branch of Japan Society of Hepatology

Date: December 12-13, 2019

Venue: Kaikyo Messe Shimonoseki, Yamaguchi, Japan

  • Presentation:
    • Title: Human Allogeneic Liver Progenitor Cells (HALPC) (HepaStem™) clinical development for Acute-on-Chronic Liver Failure and NASH
    • Date: December 12, 2019
    • Presenter: Etienne Sokal, M.D., Ph.D., Group CMO, acting CSO
Sign Up